MELIORA Data Collection Campaigns
DCC
Data Collection Campaigns for Early Development Versions of the MELIORA Digital Tools
1 other identifier
interventional
300
4 countries
7
Brief Summary
To support the development of the MELIORA digital app for the MELIORA main intervention, an initial pilot study (Data Collection Campaign, DCC) is being conducted with the three target participant groups: healthy women at increased risk of developing breast cancer (BC), BC patients, and BC survivors across the four intervention countries (Spain, Greece, Lithuania, Sweden). The planned sample size for each group is 156 healthy women at risk (defined as not meeting recommendations for a healthy lifestyle), 58 BC patients, and 86 BC survivors. Each participant is asked to test and evaluate a preliminary version of the MELIORA app over a 14-day period. The DCC takes place in the early stages of the project, as part of the intervention development phase, to inform the technical refinement and preliminary evaluation of the MELIORA digital app.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2025
Shorter than P25 for not_applicable
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 22, 2025
CompletedFirst Submitted
Initial submission to the registry
September 16, 2025
CompletedFirst Posted
Study publicly available on registry
September 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2025
CompletedSeptember 30, 2025
September 1, 2025
5 months
September 16, 2025
September 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Usability
Assessment of the usability of the first versions of the MELIORA app and users' feedback for further refinement. Participants' experiences and evaluations of the MELIORA app will be collected through a 29-item questionnaire developed for the purposes of the study. Initial questionnaire items were based on the mHealth App Usability Questionnaire (MAUQ) and the Trust in Technology framework, with additional items included to allow evaluations of specific app features. The questionnaire comprises 27 close-ended (with a 1-5 rating Likert scale) and 2 open-ended questions aiming to explore the usability and usefulness of the app, and participants' overall satisfaction with it.
14 days
Relevance, appropriateness and usefulness
Users' feedback on the relevance, appropriateness and usefulness of the MELIORA app's educational content and format. Participants will be asked to evaluate the educational materials received, through a pop-up form which will occur at the end of their interaction with each material. The form will contain four questions (with a 1 to 5 rating Likert scale) aiming to gain participants' feedback on the usefulness, relevance, and comprehensibility of the provided materials
14 days
Study Arms (1)
DCC participants
EXPERIMENTALParticipants will recieve a preliminary version of the MELIORA VCI app
Interventions
Participants will be asked to download the MELIROA app, compatible with iOS and Android, to their smartphones and test it for 14 days. The app will prompt the user to set a weekly goal on physical activity and support daily self-monitoring and step count tracking. Τhe app will also offer culturally adapted educational material through mini-courses, motivational and practical tips and an embedded library of materials relevant to physical activity, healthy diet and alcohol consumption. To boost motivation, it will also include reminders and gamification features like badges and points.
Eligibility Criteria
You may qualify if:
- Individuals residing in Greece, Lithuania, Spain or Sweden.
- Female adults (i.e. ≥18 years of age).
- Ability to understand and complete the outcome measures in one of the participating countries' local languages.
- Ability to provide fully informed consent.
- Having access to and being able to use a smartphone that supports the project app (i.e., iOS or Android smartphone)
- Meeting the criteria for allocation to one of the three following groups:
- Healthy women with a calculated Βody Μass Ιndex (BMI) ≥ 25 or not meeting the World Health Organization's recommendations of ≥150 minutes of moderate-to-vigorous physical activity per week.
- Women currently undergoing active treatment for breast cancer or awaiting to begin active treatment for breast cancer.
- Women survivors of BC having completed active treatment at least six months prior to study enrolment
You may not qualify if:
- Inability to provide fully informed consent.
- Inability to understand and communicate in one of the recruitment countries' local languages.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Harokopio Universitylead
- BROSTCANCERFORENINGEN AMAZONA I STOCKHOLMS LANcollaborator
- FUNDACION PARA LA INVESTIGACION DEL HOSPITAL CLINICO DE LA COMUNITAT VALENCIANA, FUNDACION INCLIVAcollaborator
- Instituto de Investigacion Sanitaria INCLIVAcollaborator
- LIETUVOS SVEIKATOS MOKSLU UNIVERSITETAScollaborator
- PAGALBOS ONKOLOGINIAMS LIGONIAMS ASOCIACIJAcollaborator
- SWPS UNIWERSYTET HUMANISTYCZNOSPOLECZNYcollaborator
- EUROPEAN FOOD INFORMATION COUNCILcollaborator
- ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIScollaborator
- EXUS SOFTWARE MONOPROSOPI ETAIRIA PERIORISMENIS EVTHINIScollaborator
- RISA SICHERHEITSANALYSEN GMBHcollaborator
- BIOASSIST SAcollaborator
- EUROPEAN HEALTH MANAGEMENT ASSOCIATIONcollaborator
- ETICAS DATA SOCIETYcollaborator
- Karolinska Institutetcollaborator
- PREDICTBY RESEARCH AND CONSULTING S.L.collaborator
Study Sites (7)
Harokopio University
Athens, Greece
Lietuvos Sveikatos Mokslų Universitetas (Lsmu)
Kaunas, Lithuania
Pagalbos Onkologiniams Ligoniams Asociacija (Pola L T)
Kaunas, Lithuania
Fundación Para El Fomento de La Investigación Sanitaria Y Biomédica de La Comunitat Valenciana (Fisabio)
Valencia, Spain
INCLIVA - Instituto de Investigación Sanitaria
Valencia, Spain
Bröstcancerföreningen Amazona I Stockholms Län (Amazona)
Stockholm, Sweden
Karolinska Institutet
Stockholm, Sweden
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yannis Manios, Professor
Department of Nutrition and Dietetics, School of Health Science & Education, Harokopio University, Athens, Greece
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 16, 2025
First Posted
September 24, 2025
Study Start
April 22, 2025
Primary Completion
September 30, 2025
Study Completion
September 30, 2025
Last Updated
September 30, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share
This is a pilot study aiming to gather user feedback to improve the MELIORA digital app to be ready for the main MELIORA intervention.